Marcia Poland

1.2k total citations
33 papers, 698 citations indexed

About

Marcia Poland is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Marcia Poland has authored 33 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pharmacology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Marcia Poland's work include Blood Pressure and Hypertension Studies (14 papers), Hormonal Regulation and Hypertension (8 papers) and Inflammatory mediators and NSAID effects (6 papers). Marcia Poland is often cited by papers focused on Blood Pressure and Hypertension Studies (14 papers), Hormonal Regulation and Hypertension (8 papers) and Inflammatory mediators and NSAID effects (6 papers). Marcia Poland collaborates with scholars based in United States, United Kingdom and Germany. Marcia Poland's co-authors include Eric L. Michelson, John D. Wallin, William H. Frishman, Walter Flamenbaum, Bernard Shapiro, George E. Ehrlich, Anthony R. Green, Shalom A. Leon, Donald G. Vidt and Brian F. G. Johnson and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and The American Journal of Cardiology.

In The Last Decade

Marcia Poland

32 papers receiving 616 citations

Peers

Marcia Poland

CCM

PHARM

SURGE

RNMI

RHEUM

Bianca M. Simonetti Italy

Robert E. Bowden United States

Aida Yared United States

Michael Pepoy United States

Anders Hägg Sweden

Stefania Gaino Italy

Fabio Marsico Italy

Federico Bertocchi Italy

Hajime Nakahama Japan

C Kluft Netherlands

Bianca M. Simonetti Italy

Marcia Poland

215 ×0.7

CCM

417 ×2.1

PHARM

83 ×0.5

SURGE

55 ×0.5

RNMI

116 ×1.3

RHEUM

Citations per year, relative to Marcia Poland Marcia Poland (= 1×) peers Bianca M. Simonetti

Countries citing papers authored by Marcia Poland

Since Specialization

Citations

This map shows the geographic impact of Marcia Poland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcia Poland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcia Poland more than expected).

Fields of papers citing papers by Marcia Poland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcia Poland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcia Poland. The network helps show where Marcia Poland may publish in the future.

Co-authorship network of co-authors of Marcia Poland

This figure shows the co-authorship network connecting the top 25 collaborators of Marcia Poland. A scholar is included among the top collaborators of Marcia Poland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcia Poland. Marcia Poland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomas, David H., Mairéad Butler, Thomas Anderson, et al.. (2008). Single Microbubble Response Using Pulse Sequences: Initial Results. Ultrasound in Medicine & Biology. 35(1). 112–119. 18 indexed citations

Holmes, David R., Peter J. Fitzgerald, Sheldon Goldberg, et al.. (2000). The PRESTO (Prevention of Restenosis with Tranilast and its Outcomes) protocol: A double-blind, placebo-controlled trial. American Heart Journal. 139(1). 23–31. 63 indexed citations

Dujovne, Carlos A., et al.. (2000). Randomized Comparison of the Efficacy and Safety of Cerivastatin and Pravastatin in 1030 Hypercholesterolemic Patients. Mayo Clinic Proceedings. 75(11). 1124–1132. 16 indexed citations

Schnitzer, Thomas J., et al.. (1998). Effect of nabumetone on hemostasis during arthroscopic knee surgery. Clinical Therapeutics. 20(1). 110–124. 8 indexed citations

Poland, Marcia, et al.. (1993). Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. The American Journal of Medicine. 95(2). S10–S18. 45 indexed citations

Morgan, G. James, et al.. (1993). Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly. The American Journal of Medicine. 95(2). S19–S27. 27 indexed citations

Poland, Marcia, et al.. (1993). Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. The American Journal of Medicine. 95(2). S2–S9. 52 indexed citations

Schoenberger, James A., William H. Frishman, John D. Wallin, et al.. (1989). Dilevalol compared with propranolol and placebo for systemic hypertension. The American Journal of Cardiology. 63(19). I45–I49. 8 indexed citations

Schoenberger, James A., John D. Wallin, Michael Davidov, et al.. (1989). A Multicenter Double-Blind Study of the Efficacy and Safety of Once and Twice Daily Dilevalol Compared to Propranolol. American Journal of Hypertension. 2(11 Pt 1). 840–846. 1 indexed citations

10.

Strom, Joel A., et al.. (1989). Mechanism of antihypertensive action of dilevalol compared with that of “cardioselective” beta-blocking agents. The American Journal of Cardiology. 63(19). I25–I33. 15 indexed citations

11.

Frishman, William H., Stephen P. Glasser, Joel A. Strom, et al.. (1989). Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients. The American Journal of Cardiology. 63(19). I69–I74. 7 indexed citations

12.

Clifton, G, et al.. (1989). The Renal Function and Blood Pressure Effects of Dilevalol in the Normotensive and Hypertensive Elderly. The Journal of Clinical Pharmacology. 29(7). 603–608. 2 indexed citations

13.

Frishman, William H., et al.. (1988). Multicenter Comparison of Dilevalol to Placebo in Patients with Mild Hypertension. American Journal of Hypertension. 1(3 Pt 3). 295S–299S. 7 indexed citations

14.

Wallin, John D., et al.. (1988). Renal function effects of dilevalol, a nonselective beta-adrenergic blocking drug with beta-2 agonist activity. Clinical Pharmacology & Therapeutics. 43(4). 393–399. 14 indexed citations

15.

Flamenbaum, Walter, et al.. (1985). Monotherapy with labetalol compared with propranolol. Differential effects by race.. PubMed. 1(1). 56–69. 38 indexed citations

16.

Wilson, Daniel J., John D. Wallin, N. D. Vlachakis, et al.. (1983). Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies. The American Journal of Medicine. 75(4). 95–102. 82 indexed citations

17.

Michelson, Eric L., William H. Frishman, James E. Lewis, et al.. (1983). Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension. The American Journal of Medicine. 75(4). 68–80. 19 indexed citations

18.

Bloomfield, Saul S., et al.. (1983). Step II treatment with labetalol for essential hypertension. The American Journal of Medicine. 75(4). 81–86. 5 indexed citations

19.

Frishman, William H., Joel A. Strom, Marc W. Kirschner, et al.. (1981). Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade. The American Journal of Cardiology. 48(5). 917–928. 41 indexed citations

20.

Frishman, William H., Marc W. Kirschner, Joel A. Strom, et al.. (1981). Labetalol therapy in angina pectoris and systemic hypertension: Effects of combined alpha-beta adrenergic block-ade. The American Journal of Cardiology. 47. 430–430. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact